Senior insider sale
Chief Scientific Officer at NUVALENT, INC. — senior position signals high conviction
$2.68M
29.43K shares
What this filing means
PELISH HENRY E. plans to sell 29.43K shares of NUVALENT, INC. valued at approximately $2.68M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/5/2026ACC: 0001193125-26-003156
Officer· Chief Scientific Officer
Since Mar 2026
29.43K
Shares to sell
$2.68M
Approx. market value
5.16K
Acquired (3 months)
2
Planned
3 completed
Securities Acquired — Last 3 Months2
Restricted Stock Unit Vesting
Equity Compensation
1/6/2026
2.66KRestricted Stock Unit Vesting
Equity Compensation
1/5/2026
2.50KTotal acquired5.16K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/6/2026 | Restricted Stock Unit Vesting Equity Compensation | 2.66K | — |
1/5/2026 | Restricted Stock Unit Vesting Equity Compensation | 2.50K | — |
| Total | 5.16K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
14.21K
Market value
$1.28M
10/15/2025
—Completed
Units to sell
2.43K
Market value
$208.7K
10/14/2025
—Completed
Units to sell
7.64K
Market value
$685.9K
10/13/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
2.66K
Market value
$260.9K
1/6/2026
NASDAQPlanned
Units to sell
2.50K
Market value
$242.9K
1/5/2026
Total
Units
29.43K
Value
$2.68M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
10/15/2025 | 14.21K | $1.28M | — | Completed |
10/14/2025 | 2.43K | $208.7K | — | Completed |
10/13/2025 | 7.64K | $685.9K | — | Completed |
| Planned — Approximate Date | ||||
1/6/2026 | 2.66K | $260.9K | NASDAQ | Planned |
1/5/2026 | 2.50K | $242.9K | NASDAQ | Planned |
| Total | 29.43K | $2.68M | ||